Detalhe da pesquisa
1.
Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic.
Genes Dev
; 36(5-6): 259-277, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318270
2.
Moving toward disease modification in polycythemia vera.
Blood
; 142(22): 1859-1870, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729609
3.
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Blood
; 141(17): 2047-2061, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724453
4.
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Ann Hematol
; 103(1): 105-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036712
5.
Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood-brain barrier function.
J Neuroinflammation
; 20(1): 267, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978545
6.
Plasma renalase levels are associated with the development of acute pancreatitis.
Pancreatology
; 23(2): 158-162, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697349
7.
Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?
J Natl Compr Canc Netw
; 21(5): 522-528, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037494
8.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251406
9.
Azacitidine maintenance in AML post induction and posttransplant.
Curr Opin Hematol
; 29(2): 84-91, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013047
10.
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes.
Ann Hematol
; 101(3): 557-569, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981142
11.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Am J Hematol
; 97(3): 322-328, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981560
12.
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept.
Curr Opin Oncol
; 33(6): 658-669, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341323
13.
Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 cases.
J Thromb Thrombolysis
; 52(3): 854-862, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765243
14.
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis.
Haematologica
; 105(1): 102-111, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004015
15.
Evolving therapies for lower-risk myelodysplastic syndromes.
Ann Hematol
; 99(4): 677-692, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078008
16.
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.
Cancer
; 125(23): 4241-4251, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483484
17.
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia.
Blood
; 139(11): 1766-1770, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298594
18.
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Blood
; 140(3): 285-289, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507690
19.
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Am J Hematol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751104
20.
Challenges in HSV encephalitis: normocellular CSF, unremarkable CCT, and atypical MRI findings.
Infection
; 47(2): 267-273, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506479